Xiaorong Zhou

23PUBLICATIONS
33CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 20, 2026
Engineered Neutrophils in Translational Medicine: Gene Editing, Nanotechnology, and AI-Driven Clinical Breakthroughs.

|Jun 03, 2026
Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in KRAS-mutant non-small cell lung cancer.

|Jan 28, 2026
Betaine Inhibits Ferroptosis After Intracerebral Hemorrhage by Activating the Nrf2/HO-1 Pathway.

Jie Chen, Xurui Lu, Sunqian Liu

|Oct 28, 2025
Constructing a Pan-Cancer Prognostic Model via Machine Learning Based on Immunogenic Cell Death Genes and Identifying NT5E as a Biomarker in Head and Neck Cancer.

Luojin Wu, Qing Sun, Atsushi Kitani

|Jun 21, 2025
The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis.

Ling Zuo, Xinru Zou, Jia Ge

|Feb 01, 2025
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy.

Shishengnan Song, Chong Wang, Yangchao Chen

Pageof 4

Frequent Collaborators

7 joint publications

Liming Mao

1 joint publications

Xiao Zhu

1 joint publications

Da Fu

1 joint publications

Jun Ni